Agilon Health
185 hedge funds and large institutions have $7.67B invested in Agilon Health in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 39 reducing their positions, and 47 closing their positions.
210% more call options, than puts
Call options by funds: $39.1M | Put options by funds: $12.6M
138% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 39
0.06% less ownership
Funds ownership: 4.33% → 4.27% (-0.06%)
7% less funds holding
Funds holding: 198 → 185 (-13)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 47
28% less capital invested
Capital invested by funds: $10.6B → $7.67B (-$2.95B)
Top Buyers
Top Sellers
| 1 |
CDR
Clayton Dubilier & Rice
New York
|
-$2.13B |
| 2 |
HF
HRT Financial
New York
|
-$22.6M |
| 3 |
Amundi
Paris,
France
|
-$9.46M |
| 4 |
Jane Street
New York
|
-$8.01M |
| 5 |
BBL
Beck Bode LLC
Dedham,
Massachusetts
|
-$4.04M |
AGL Hedge Fund Activity: Q2 2023 in Review
185 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2023, worth a combined $7.67B — down 28% from $10.6B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of AGL and 34 opened new positions — a net loss of 13 holders — while 39 trimmed existing stakes and 93 added.
The largest buyer was Wellington Management Group, adding an estimated $400M. The largest seller was Clayton Dubilier & Rice, cutting an estimated $2.13B.
- 185 institutional investors held Agilon Health (AGL) as of Q2 2023, down from 198 in Q1 2023.
- Funds reported $7.67B of Agilon Health stock for Q2 2023, down 28% quarter-over-quarter.
- 34 funds opened new Agilon Health positions in Q2 2023 and 47 closed out, a net change of -13 holders.
- The largest Agilon Health buyer in Q2 2023 was Wellington Management Group, an estimated $400M added.
- The largest Agilon Health seller in Q2 2023 was Clayton Dubilier & Rice, an estimated $2.13B sold.
Based on aggregated 13F filings for Q2 2023.